Physician profile
Daisy Gonzalez
NPI 1114507407
$1,208.72
in general payments reported to CMS, 2019-2025
8 companies · $472 in 2025
The $472 reported for 2025 was more than what 78% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $28.14 · 2022: $325 · 2023: $61.78 · 2024: $321 · 2025: $472.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $856.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $855.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $434.97 | 2024-2025 | Novosorb Btm |
| Abbvie INC. | $358.77 | 2024-2025 | |
| Allergan, INC. | $127.91 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $122.10 | 2022 | |
| Olympus America INC. | $76.43 | 2021-2022 | |
| Kci USA, INC. | $36.11 | 2023 | Prevena, V.A.C. Veraflo Cleanse Choice |
| Telix Pharmaceuticals | $26.76 | 2022 | |
| Sumitomo Pharma America, INC. | $25.67 | 2023 | Gemtesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daisy Gonzalez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.